1-(5-isoquinolinesulfonyl)-2-methylpiperazine has been researched along with calpain in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fukami, M; Maeda, Y; Minami, N; Tani, E; Yamaura, I | 1 |
| Gu, XM; Jin, ZX; Kong, LH; Wu, F; Zhou, JJ | 1 |
2 other study(ies) available for 1-(5-isoquinolinesulfonyl)-2-methylpiperazine and calpain
| Article | Year |
|---|---|
Effects of inhibitors of protein kinase C and calpain in experimental delayed cerebral vasospasm.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Animals; Basilar Artery; Calpain; Dipeptides; Dogs; Ischemic Attack, Transient; Isoquinolines; Naphthalenes; Piperazines; Polycyclic Compounds; Protein Kinase C; Vasoconstriction | 1992 |
CaMKII inhibition mitigates ischemia/reperfusion-elicited calpain activation and the damage to membrane skeleton proteins in isolated rat hearts.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Animals; Benzylamines; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Calpain; Cytoskeletal Proteins; Enzyme Activation; Enzyme Inhibitors; Heart; In Vitro Techniques; Male; Membrane Proteins; Myocardial Reperfusion Injury; Myocardium; Rats; Rats, Sprague-Dawley; Sulfonamides; Treatment Outcome | 2017 |